Evidence map›Paper›PMID 37732545›Full record

ReviewClinical science (London, England : 1979)2023

Edema and lymphatic clearance: molecular mechanisms and ongoing challenges.

Jerome W Breslin

Abstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jerome W BreslinDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, FL, U.S.A.

Funding

Microvascular Leakage in Hemorrhagic Shock and TraumaR35GM145379 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI JEROME W BRESLIN · 2022 to 2026
$2.0M
Obesity, Metabolic Syndrome, and Lymphatic DysfunctionR56HL153542 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI BRESLIN, JEROME W · 2022 to 2022
$601k
mHealth for Heart Failure: Predictive Models of Readmission Risk and Self-care Using Consumer Activity TrackersR56HL135425 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARNOLD, COREY WELLS · 2017 to 2017
$599k
NHLBI NIH HHS R56 HL135425NHLBI NIH HHS R56 HL153542NIGMS NIH HHS R35 GM145379
6 · The paper itself

Abstract

Resolution of edema remains a significant clinical challenge. Conditions such as traumatic shock, sepsis, or diabetes often involve microvascular hyperpermeability, which leads to tissue and organ dysfunction. Lymphatic insufficiency due to genetic causes, surgical removal of lymph nodes, or infections, leads to varying degrees of tissue swelling that impair mobility and immune defenses. Treatment options are limited to management of edema as there are no specific therapeutics that have demonstrated significant success for ameliorating microvascular leakage or impaired lymphatic function. This review examines current knowledge about the physiological, cellular, and molecular mechanisms that control microvascular permeability and lymphatic clearance, the respective processes for interstitial fluid formation and removal. Clinical conditions featuring edema, along with potential future directions are discussed.

Indexed as

EdemaSepsisCapillary PermeabilityHumansKineticsendothelial cellslymph formationmicrovascular permeability

Identifiers

PMID37732545
PMCPMC11025659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.